Date: 2016-07-01
Type of information: Nomination
Compound:
Company: Valneva (France- Austria)
Therapeutic area: Infectious diseases
Type agreement: nomination
Action mechanism:
Disease:
Details: * On July 1, 2016, Valneva announced the appointment of Ralf Clemens, former Head of Global Vaccine Development at Novartis Vaccines & Diagnostics amongst other leading positions, and Lisa Shaw-Marotto, former Head of Global Commercial Services at Merck&Co to its Supervisory Board. Dr. Clemens and Ms. Shaw-Marotto each bring decades of strategic, operational and management experience in the pharmaceutical industry to Valneva’s board and, in particular, strong expertise in infectious diseases, vaccine development and marketing. Dr. Clemens and Ms. Shaw-Marotto replace current Supervisory Board members Michel Greco and Hans Wigzell whose term of office expired on June 30. Dr. Clemens, MD., PhD., has been working in the vaccine industry since 1988 in various senior scientific and commercial positions including Senior Vice President of Development for the Global Vaccine Business Unit at Takeda Pharmaceuticals International, Vice President Global Clinical R&D of GSK Vaccines and of GSK’s Pharmaceuticals and Vaccines in Latin America, and Head of Global Vaccine development at Novartis. He currently serves as Senior Vice President at GRID Rio (Global Research in Infectious Diseases) and advisor to the Bill & Melinda Gates Foundation. Dr. Clemens is the author of more than 150 publications and 250 presentations in the fields of vaccines, immunization and tropical medicine. He received an MD degree from the University of Mainz, Germany, and holds an executive business degree from the Wharton Business School, Philadelphia, US.
Ms. Lisa Shaw-Marotto spent most of her career at Merck & Co. where she held commercial roles of increasing responsibility, culminating in her appointment as Vice President of Marketing. In this position, she led Merck's Global Commercial Services organization, and was responsible for market research, training, marketing communications and marketing operations. Ms. Shaw-Marotto is currently the President of Executive Perspective Consulting LLC, a life sciences consulting company she founded in 2014. She holds a biomedical science degree from the University of Technology in Sydney, Australia.
Bpifrance Participations SA, the investment arm of French state-owned bank BPI France SA, and currently Valneva’s second largest shareholder, was also appointed as a member of Valneva’s Supervisory board during the Company’s Combined General Meeting. BPI France Participations SA had been sitting as an observer on Valneva’s Supervisory board since 2013.
Financial terms:
Latest news:
